A single cell assay for tissue activity
A single cell assay for tissue activity
批准号:
10831316
负责人:
ANDREI GOGA
金额:
$16.13万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-05-01 至 2025-04-30
关键词:
ActomyosinApicalApoptosisAreaBasal CellBasic ScienceBiological AssayBiomechanicsBreast Epithelial CellsCadherinsCell divisionCell membraneCellsCellular AssayClinicalCollagen Type IVDevelopmentDiffuseDiseaseElasticityEnvironmentEpithelial CellsEpitheliumExtracellular MatrixFibronectinsFrequenciesGrantHomeostasisHumanIn SituIntercellular JunctionsInvadedLamininLateralLengthLiquid substanceMammary NeoplasmsMeasurementMeasuresMechanicsMembraneModelingMyoepithelial cellNeoplasm MetastasisNoiseOncogenesOrganoidsOutputP-CadherinPatientsPhase TransitionPhysiological ProcessesPlayProcessProductionPropertyRoleSolidSourceSurfaceSystemTissuesTractionTraction Force Microscopyassay developmentcancer cellcancer invasivenesscell behaviorcell transformationexosomeinterestmammary epitheliumneoplastic cellpolyacrylamide gelsprofessorprogramsresponsetumor microenvironmenttumor progressionwound healing
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
This application is being submitted in response to the Notice of Special Interest (NOSI) identified as NOT-CA-
23-045.
Fluctuations in the active biomechanical properties of cells are understudied, but evidence suggest they play a
critical role in both core physiological processes and in disease. For example, tissue phase transitions, from
elastic- to fluid-like (or jammed to unjammed) are thought to arise in part from increased noise in cell junctional
mechanics. These forces can also result in shedding of cellular material like exosomes. Both of these
processes play a central role in cancer progression, most notably in invasion and metastasis. However, a
major challenge is identifying the specific subcellular origin of these forces and the machinery responsible for
them. For example, studies of tissue fluidization using vertex modeling approaches have defined the necessary
and sufficient geometric changes for tissue fluidization in epithelia. Specifically, active fluctuations in cell
junction length are required for the T1 transitions that change junctional topology and allow cells to diffuse like
a fluid. Actomyosin dynamics can drive these transition in the absence of cell division and apoptosis, but these
models focus on actomyosin activity at apical/lateral interfaces (between cells), but largely ignore more indirect
sources of activity, for example deriving from tractions generated at the basal surface which acts to sheer
lateral and apical cell junctions. By tracking the dynamics of single cells in both normal and transformed
primary human mammary epithelial organoids we see evidence that the activity necessary to fluidize a tissue
derives from interactions between cells and their basal interface at the ECM. At the single cell level, we reason
that this activity manifests as fluctuations in cell tractions, specifically at basal cell-ECM interfaces, and at the
tens of minutes timescale. In this supplemental proposal, we will first develop a platform allowing the
measurement of dynamic cell tractions at the cell-ECM interface which we will apply to single normal and
transformed mammary epithelial cells. Second, we will develop a parallel assay for measuring cell tractions at
the cell-cell interface. We hypothesize that the magnitude of fluctuations at the cell-ECM interface will be
several fold higher than at lateral interfaces, and that the largest fluctuations will occur at the tens of minutes
timescale, consistent with that of junctional fluctuations in intact tissues. Successful development of this assay
will allow us to investigate the impact of mechanical fluctuations in processes spanning tissue fluidization,
cancer cell invasions, and exosome shedding.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.ceb.2020.05.003
发表时间:
2020-10
期刊:
Current opinion in cell biology
影响因子:
7.5
作者:
[Srivastava V, Huycke TR, Phong KT, Gartner ZJ]
通讯作者:
Gartner ZJ
Understanding CDK1 Function and Cancer Vulnerabilities
-
批准号:10736617
-
项目类别:
-
资助金额:$48.39万
-
财政年份:2023
-
负责人:ANDREI GOGA
-
依托单位:
Understanding breast cancer progression as a defect in the mechanics of tissue self-organization
-
批准号:10395995
-
项目类别:
-
资助金额:$56.62万
-
财政年份:2020
-
负责人:ANDREI GOGA
-
依托单位:
Understanding breast cancer progression as a defect in the mechanics of tissue self-organization
-
批准号:10613917
-
项目类别:
-
资助金额:$48.8万
-
财政年份:2020
-
负责人:ANDREI GOGA
-
依托单位:
Uncovering Mechanisms of Regulation and Dependency on Fatty Acid Oxidation in MYC-Driven Tumors
-
批准号:10194413
-
项目类别:
-
资助金额:$36.94万
-
财政年份:2018
-
负责人:ANDREI GOGA
-
依托单位:
Uncovering Mechanisms of Regulation and Dependency on Fatty Acid Oxidation in MYC-Driven Tumors
-
批准号:10436804
-
项目类别:
-
资助金额:$36.2万
-
财政年份:2018
-
负责人:ANDREI GOGA
-
依托单位:
In Vivo Metabolic Catastrophe Is Induced By Acute Oncogene Inhibition (PQ #22)
-
批准号:8676483
-
项目类别:
-
资助金额:$59.3万
-
财政年份:2012
-
负责人:ANDREI GOGA
-
依托单位:
In Vivo Metabolic Catastrophe Is Induced By Acute Oncogene Inhibition (PQ #22)
-
批准号:8384577
-
项目类别:
-
资助金额:$61.1万
-
财政年份:2012
-
负责人:ANDREI GOGA
-
依托单位:
In Vivo Metabolic Catastrophe Is Induced By Acute Oncogene Inhibition (PQ #22)
-
批准号:8513950
-
项目类别:
-
资助金额:$57.36万
-
财政年份:2012
-
负责人:ANDREI GOGA
-
依托单位:
Targeting the MYC Oncogene with CDK Inhibitors
-
批准号:8641666
-
项目类别:
-
资助金额:$34.17万
-
财政年份:2010
-
负责人:ANDREI GOGA
-
依托单位:
Targeting the MYC Oncogene with CDK Inhibitors
-
批准号:7890072
-
项目类别:
-
资助金额:$38.13万
-
财政年份:2010
-
负责人:ANDREI GOGA
-
依托单位:
Targeting the MYC Oncogene with CDK Inhibitors
-
批准号:8220841
-
项目类别:
-
资助金额:$36.19万
-
财政年份:2010
-
负责人:ANDREI GOGA
-
依托单位:
Targeting the MYC Oncogene with CDK Inhibitors
-
批准号:8458489
-
项目类别:
-
资助金额:$33.56万
-
财政年份:2010
-
负责人:ANDREI GOGA
-
依托单位:
Targeting the MYC Oncogene with CDK Inhibitors
-
批准号:8063614
-
项目类别:
-
资助金额:$36.69万
-
财政年份:2010
-
负责人:ANDREI GOGA
-
依托单位:
CDK Inhibition in Cancer
-
批准号:7274257
-
项目类别:
-
资助金额:$12.72万
-
财政年份:2005
-
负责人:ANDREI GOGA
-
依托单位:
CDK Inhibition in Cancer
-
批准号:7097472
-
项目类别:
-
资助金额:$12.72万
-
财政年份:2005
-
负责人:ANDREI GOGA
-
依托单位:
CDK Inhibition in Cancer
-
批准号:6967425
-
项目类别:
-
资助金额:$12.69万
-
财政年份:2005
-
负责人:ANDREI GOGA
-
依托单位:
CDK Inhibition in Cancer
-
批准号:7663857
-
项目类别:
-
资助金额:$12.72万
-
财政年份:2005
-
负责人:ANDREI GOGA
-
依托单位:
CDK Inhibition in Cancer
-
批准号:7468349
-
项目类别:
-
资助金额:$12.72万
-
财政年份:2005
-
负责人:ANDREI GOGA
-
依托单位:
Molecular and Cellular Mechanisms in Cancer
-
批准号:10021940
-
项目类别:
-
资助金额:$57.15万
-
财政年份:2004
-
负责人:ANDREI GOGA
-
依托单位:
Molecular and Cellular Mechanisms in Cancer
-
批准号:10687834
-
项目类别:
-
资助金额:$55.87万
-
财政年份:2004
-
负责人:ANDREI GOGA
-
依托单位:
国内基金
海外基金
FGF8通过Ras/MEK/ERK信号通路调控apical ES结构影响精子生成的机制研究
-
批准号:81801519
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2018
-
负责人:于岚
-
依托单位: